BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 16455962)

  • 1. Cutting edge: enhancement of antibody responses through direct stimulation of B and T cells by type I IFN.
    Le Bon A; Thompson C; Kamphuis E; Durand V; Rossmann C; Kalinke U; Tough DF
    J Immunol; 2006 Feb; 176(4):2074-8. PubMed ID: 16455962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early type I interferon-mediated signals on B cells specifically enhance antiviral humoral responses.
    Fink K; Lang KS; Manjarrez-Orduno N; Junt T; Senn BM; Holdener M; Akira S; Zinkernagel RM; Hengartner H
    Eur J Immunol; 2006 Aug; 36(8):2094-105. PubMed ID: 16810635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct stimulation of T cells by type I IFN enhances the CD8+ T cell response during cross-priming.
    Le Bon A; Durand V; Kamphuis E; Thompson C; Bulfone-Paus S; Rossmann C; Kalinke U; Tough DF
    J Immunol; 2006 Apr; 176(8):4682-9. PubMed ID: 16585561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-alphabeta mediates partial control of early pulmonary Mycobacterium bovis bacillus Calmette-Guérin infection.
    Kuchtey J; Fulton SA; Reba SM; Harding CV; Boom WH
    Immunology; 2006 May; 118(1):39-49. PubMed ID: 16630021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STAT1 regulates IFN-alpha beta- and IFN-gamma-dependent control of infection with Chlamydia pneumoniae by nonhemopoietic cells.
    Rothfuchs AG; Trumstedt C; Mattei F; Schiavoni G; Hidmark A; Wigzell H; Rottenberg ME
    J Immunol; 2006 Jun; 176(11):6982-90. PubMed ID: 16709859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I IFN receptor signals directly stimulate local B cells early following influenza virus infection.
    Coro ES; Chang WL; Baumgarth N
    J Immunol; 2006 Apr; 176(7):4343-51. PubMed ID: 16547272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral infection causes rapid sensitization to lipopolysaccharide: central role of IFN-alpha beta.
    Nansen A; Randrup Thomsen A
    J Immunol; 2001 Jan; 166(2):982-8. PubMed ID: 11145676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A lymphotoxin-IFN-beta axis essential for lymphocyte survival revealed during cytomegalovirus infection.
    Banks TA; Rickert S; Benedict CA; Ma L; Ko M; Meier J; Ha W; Schneider K; Granger SW; Turovskaya O; Elewaut D; Otero D; French AR; Henry SC; Hamilton JD; Scheu S; Pfeffer K; Ware CF
    J Immunol; 2005 Jun; 174(11):7217-25. PubMed ID: 15905567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depletion of T cells by type I interferon: differences between young and aged mice.
    Jiang J; Gross D; Nogusa S; Elbaum P; Murasko DM
    J Immunol; 2005 Aug; 175(3):1820-6. PubMed ID: 16034124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes simplex virus type 2 virion host shutoff protein regulates alpha/beta interferon but not adaptive immune responses during primary infection in vivo.
    Murphy JA; Duerst RJ; Smith TJ; Morrison LA
    J Virol; 2003 Sep; 77(17):9337-45. PubMed ID: 12915549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory responses to pneumovirus infection in IFN-alpha beta R gene-deleted mice.
    Garvey TL; Dyer KD; Ellis JA; Bonville CA; Foster B; Prussin C; Easton AJ; Domachowske JB; Rosenberg HF
    J Immunol; 2005 Oct; 175(7):4735-44. PubMed ID: 16177121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical.
    Shresta S; Kyle JL; Snider HM; Basavapatna M; Beatty PR; Harris E
    J Virol; 2004 Mar; 78(6):2701-10. PubMed ID: 14990690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutting Edge: The direct action of type I IFN on CD4 T cells is critical for sustaining clonal expansion in response to a viral but not a bacterial infection.
    Havenar-Daughton C; Kolumam GA; Murali-Krishna K
    J Immunol; 2006 Mar; 176(6):3315-9. PubMed ID: 16517698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of a human antibody response in vitro mediated by interaction of interferon-alpha with T lymphocytes.
    Evans SS; Ozer H
    J Immunol; 1987 Apr; 138(8):2451-6. PubMed ID: 2951440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLR signaling fine-tunes anti-influenza B cell responses without regulating effector T cell responses.
    Heer AK; Shamshiev A; Donda A; Uematsu S; Akira S; Kopf M; Marsland BJ
    J Immunol; 2007 Feb; 178(4):2182-91. PubMed ID: 17277123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type I IFN signaling is crucial for host resistance against different species of pathogenic bacteria.
    Mancuso G; Midiri A; Biondo C; Beninati C; Zummo S; Galbo R; Tomasello F; Gambuzza M; Macrì G; Ruggeri A; Leanderson T; Teti G
    J Immunol; 2007 Mar; 178(5):3126-33. PubMed ID: 17312160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role for innate IFNs in determining respiratory syncytial virus immunopathology.
    Johnson TR; Mertz SE; Gitiban N; Hammond S; Legallo R; Durbin RK; Durbin JE
    J Immunol; 2005 Jun; 174(11):7234-41. PubMed ID: 15905569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay between alpha/beta and gamma interferons with B, T, and natural killer cells in the defense against herpes simplex virus type 1.
    Vollstedt S; Arnold S; Schwerdel C; Franchini M; Alber G; Di Santo JP; Ackermann M; Suter M
    J Virol; 2004 Apr; 78(8):3846-50. PubMed ID: 15047800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The MyD88 pathway in plasmacytoid and CD4+ dendritic cells primarily triggers type I IFN production against measles virus in a mouse infection model.
    Takaki H; Takeda M; Tahara M; Shingai M; Oshiumi H; Matsumoto M; Seya T
    J Immunol; 2013 Nov; 191(9):4740-7. PubMed ID: 24078691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation.
    Mattei F; Schiavoni G; Belardelli F; Tough DF
    J Immunol; 2001 Aug; 167(3):1179-87. PubMed ID: 11466332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.